Safety and efficacy of Myobloc® (botulinum toxin type B) for sialorrhea in Parkinson's disease (PD) patients

被引：0
|
作者：
Pappert, Eric [1 ]
Reinhard, Sharon [1 ]
Salazar-Grueso, Edgar [1 ]
机构：
[1] Solstice Neurosci Inc, Malvern, PA USA
来源：
TOXICON | 2008年 / 51卷
关键词：
botulinum toxin B; sialorrhea;
D O I：
10.1016/j.toxicon.2008.04.154
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
152
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [41] BOTULINUM TOXIN TYPE A IN PATIENTS WITH PARKINSON'S DISEASE AND REFRACTORY OVERACTIVE BLADDER
    Silvia, Giovannozzi
    Silvia, Proietti
    Antonella, Conte
    Emanuele, Lepri
    Luca, Lepri
    Marilena, Gubbiotti
    Alfredo, Berardelli
    Antonella, Giannantoni
    NEUROUROLOGY AND URODYNAMICS, 2011, 30 : 47 - 48
  • [42] Botulinum Toxin Type A in Patients With Parkinson's Disease and Refractory Overactive Bladder
    Giannantoni, Antonella
    Conte, Antonella
    Proietti, Silvia
    Giovannozzi, Silvia
    Rossi, Aroldo
    Fabbrini, Giovanni
    Porena, Massimo
    Berardelli, Alfredo
    JOURNAL OF UROLOGY, 2011, 186 (03): : 960 - 964
  • [43] Long-term safety, efficacy, and dosing of botulinum toxin type B (Myobloc) in cervical dystonia (CD) and other movement disorders
    Kumar, R
    Seeberger, LC
    MOVEMENT DISORDERS, 2002, 17 : S292 - S293
  • [44] Safety and efficacy of neurobloc™ (botulinum toxin type B) in type a responsive cervical dystonia patients
    Brashear, A
    Lew, MF
    Dykstra, DD
    Comella, CL
    Factor, SA
    Rodnitzky, RL
    Trosch, R
    Singer, C
    Brin, MF
    Murray, JJ
    Willmer-Hulme, A
    Wallace, JD
    Koller, M
    NEUROLOGY, 1999, 52 (06) : A292 - A293
  • [45] Botulinum toxin for Sialorrhea in Patients with Parkinson's disease & Atypical Parkinsonism: A Single Center Real-World Study
    Buttar, Danyaal
    Siddiqui, Mustafa
    NEUROLOGY, 2023, 100 (17)
  • [46] BOTULINUM TOXIN TYPE A AND TYPE B FOR SIALORRHOEA IN PARKINSON'S DISEASE: A CASE FOR SWITCHING THERAPY?
    Santamato, Andrea
    Panza, Francesco
    Solfrizzi, Vincenzo
    Frisardi, Vincenza
    Ranieri, Maurizio
    Fiore, Pietro
    JOURNAL OF REHABILITATION MEDICINE, 2008, 40 (10) : 882 - 883
  • [47] Botulinum Toxin in the Management of Refractory Sialorrhea in Patients with Neuromuscular Disease
    Singh, Harsh
    Mehta, Tejas
    Singh, Shivangi
    Govindarajan, Raghav
    NEUROLOGY, 2020, 94 (15)
  • [48] Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: Rate of onset and radius of diffusion
    Flynn, TC
    Clark, RE
    DERMATOLOGIC SURGERY, 2003, 29 (05) : 519 - 522
  • [49] Botulinum toxin type a as a complementary treatment in Parkinson's disease
    Porta, M
    Camerlingo, M
    Maggioni, G
    Perretti, A
    Dell'Anna, E
    Ferrante, C
    MOVEMENT DISORDERS, 2002, 17 : S99 - S99
  • [50] Botulinum Toxin Type A for Pain in Advanced Parkinson's Disease
    Bruno, Veronica
    Freitas, Maria Eliza
    Mancini, Deborah
    Lui, Jane P.
    Miyasaki, Janis
    Fox, Susan H.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2018, 45 (01) : 23 - 29
12345